Phellinus linteus Extract Exerts Anti-asthmatic Effects by Suppressing NF-kappaB and p38 MAPK Activity in an OVA-induced Mouse Model of Asthma.
- Author:
Guang Hai YAN
1
;
Yun Ho CHOI
Author Information
- Publication Type:Original Article
- Keywords: Phellinus linteus; Asthma; Allergic inflammation; Th2 cytokine; NF-kappaB; p38
- MeSH: Administration, Oral; Animals; Asian Continental Ancestry Group; Asthma*; Bronchoalveolar Lavage Fluid; Cytokines; Eosinophils; Ethanol; Herbal Medicine; Humans; Inflammation; Inhalation; Interleukin-5; Lung; Mice*; NF-kappa B*; Ovum; p38 Mitogen-Activated Protein Kinases*
- From:Immune Network 2014;14(2):107-115
- CountryRepublic of Korea
- Language:English
- Abstract: Phellinus linteus has been used as a traditional herbal medicine in Asian countries and is known to have anti-tumor, immunomodulatory, anti-inflammatory, and anti-allergic activities. However, the protective effects of P. linteus against experimental asthma have not been fully investigated. The objective of this study was to determine whether P. linteus ethanol extract (PLE) suppresses inflammatory response in an OVA-induced asthma model. As expected, the oral administration of PLE significantly inhibited eosinophilic airway inflammation and airway hyperresponsiveness in OVA-challenged BALB/c mice. Supporting these data, the augmentation of Th2 cytokines (IL-4, IL-5, and IL-13), eotaxin, and adhesion molecules in lung tissues and bronchoalveolar lavage fluid after OVA inhalation was markedly attenuated by PLE. Furthermore, PLE reduced OVA-induced activation of NF-kappaB and p38 MAPK in lung tissues. Therefore, our results suggest the potential of P. linteus as a therapeutic agent for asthma.
